What is Liraglutide?

What the compound is and where it sits legally

Liraglutide is classified here as a metabolic peptide. Its regulatory status is the important part of that description: it has been approved by a regulator for human use in at least one market. That is not the same as being approved everywhere, for every purpose, or for the person reading this. Approval is jurisdiction-specific and indication-specific.

That status also says nothing about the specific vial in front of you. Approval attaches to a product made under a defined process and sold through a defined channel. A lyophilized vial bought outside that channel is a different object with the same name on the label. Purity, mass accuracy, and sterility are properties of the item, not of the molecule.

This page exists for one narrow reason. Vials are sold as a dry mass in milligrams. Syringes are marked in volume. Something has to convert between them, and that conversion is arithmetic you can check.

What this site does not know and will not answer

We hold no reliable human pharmacokinetic data for Liraglutide. So this site makes no claim about its half life, how long it takes to clear, how often it would need to be given, or whether repeated administration accumulates. Those are exactly the questions that determine a schedule, which is why no schedule appears on this page.

There is no medical review behind this content. It does not tell you what dose to use, what effects to expect, what adverse effects occur, whether the compound is safe, or whether it works for anything. Those are clinical questions and they need a clinician with your history in front of them. A reader arriving here looking for that answer should read this sentence as the answer: we do not provide it.

What remains is concentration and volume. Those are fixed by the mass in the vial and the water you add, and they do not depend on any biology.

Reading the concentration table

The table above lists every combination of the two vial sizes sold, 5 mg and 10 mg, with the three water volumes commonly used, 1 mL, 2 mL, and 3 mL. Three things in it are worth pausing on.

First, concentration is mass divided by volume and nothing else. Adding water does not change how much peptide you have. It changes how spread out that peptide is, which changes how much liquid carries a given amount. The 5 mg vial spans 5 mg/mL down to 1.67 mg/mL depending only on whether you add 1 mL or 3 mL.

Second, the same concentration can arrive from different starting points. A 5 mg vial in 1 mL and a 10 mg vial in 2 mL both give 5 mg/mL. The liquid in those two vials is identical in strength. The 10 mg vial simply contains twice as much of it, so it holds twice as many equal draws. This matters when comparing listings that quote a concentration without saying which vial produced it.

Third, the numbers that are not round are the ones that cause errors. 1.67 mg/mL and 3.33 mg/mL come from dividing by 3, and they do not divide back cleanly into the amounts that appear in listings. Choosing 1 mL or 2 mL of water tends to produce arithmetic you can do in your head and verify.

Turning a listed amount into a syringe volume

Listings for Liraglutide commonly quote amounts of 0.6 mg, 1.2 mg, 1.8 mg, and 3 mg. Those are figures that appear in the market. They are not recommendations from this site, and we make no statement about which, if any, is appropriate.

The conversion is one division. Take the amount in milligrams and divide it by the concentration in milligrams per milliliter from the table. The result is a volume in milliliters. To read that on a U-100 insulin syringe, remember the barrel is marked so that the full 1 mL is 100 units, so a fraction of a milliliter maps directly onto the unit marks.

Work the division in the order the physical objects come. Vial mass and water volume set the concentration. Concentration and the amount you want set the volume. If you change the water, every volume you calculated before is wrong, because the concentration underneath it changed. Write the water volume on the vial when you reconstitute it, since nothing about the finished vial reveals what went into it.

One caution on the table itself: it tells you what the concentration would be if the vial contains exactly what the label says. Fill loss, powder left on the stopper, and inaccurate fill mass all shift the real figure away from the calculated one.

What we do not know

We hold no reliable human pharmacokinetic data for Liraglutide, so this site makes no claims about its half life, how long it takes to clear, or how it accumulates. The arithmetic below concerns concentration and volume only.

This page answers arithmetic and handling questions. It does not tell you what dose to take, what to expect, or whether anything is appropriate for you, and there is no medical review behind it.

Common questions

How much bacteriostatic water should I add to a Liraglutide vial?

There is no single correct volume. The table shows 1 mL, 2 mL, and 3 mL for both the 5 mg and 10 mg vials, and each gives a different concentration. Smaller water volumes give a more concentrated solution and a smaller draw; larger volumes give a larger draw for the same mass. The choice sets your arithmetic, not the amount of peptide you have.

What is the half life of Liraglutide?

We do not state one. This site holds no reliable human pharmacokinetic data for Liraglutide, so it makes no claim about half life, clearance, or accumulation. Any figure quoted elsewhere is not something we can verify, and we will not repeat it.

Is a 5 mg vial in 1 mL the same as a 10 mg vial in 2 mL?

The concentration is the same. Both give 5 mg/mL, so a given volume drawn from either contains the same mass of peptide. The difference is total quantity: the 10 mg vial holds twice as much solution at that strength.

Which of the listed amounts should I use?

This page does not answer that. The amounts of 0.6 mg, 1.2 mg, 1.8 mg, and 3 mg are figures that appear in listings, recorded only so the volume arithmetic has something to work from. Deciding on an amount is a clinical question and there is no medical review behind this site.

Does Liraglutide being approved somewhere mean my vial is approved?

No. Approval applies to a specific product, made under a specific process, sold in a specific market for a specific use. A lyophilized vial obtained outside that route is not covered by it, and its mass accuracy, purity, and sterility are unknown to us.